Trump expected to sign executive order to reclassify marijuana as soon as Monday, source tells CNBC

Cannabis stocks jumped Friday as the White House moved to significantly ease federal restrictions on marijuana. Brandon Gomez has the latest on the timing of a potential Executive Order and why the industry says it's “more optimistic” this time around.

CNBC Television • Dec 12, 2025

Cannabis stocks surge on report Trump seeks to ease restrictions.

President Donald Trump is expected to push for marijuana reclassification from Schedule I to Schedule III status, sending cannabis stocks soaring.

Fox Business • Dec 12, 2025

Cannabis stocks spike on reports Trump plans to ease federal pot restrictions

The rally marked one of the biggest single-day moves for cannabis stocks in years, snapping a prolonged slump.

New York Post • Dec 12, 2025

Cannabis stocks surge on Trump's rumored Schedule 3 marijuana change. How high can pot shares get?

Multiple news reports this week said that President Trump is expected to reclassify marijuana's drug scheduling, which would lessen restrictions on its use and potentially allow companies that operate in the cannabis space to increase business.

Fast Company • Dec 12, 2025

5 ETFs to Watch as Restrictions on Marijuana Set to Ease

Cannabis stocks soared on Friday following news that U.S. president Donald Trump is expected to sign an executive order as soon as Monday that would ultimately ease federal restrictions on marijuana. The order would essentially reclassify marijuana from a Schedule I substance to Schedule III under the federal Controlled Substances Act.

ETF Trends • Dec 12, 2025

Trump Expected to Label Pot a Less Dangerous Drug

President Donald Trump is expected have his administration classify marijuana as a less dangerous drug, according to people familiar with the matter. This has been good news for pot stocks.

Bloomberg Markets and Finance • Dec 12, 2025

Best-Performing ETFs of Last Week

Cannabis, nat gas, space & meme ETFs surged last week: WEED, MSOS, UNG, UNL, UFO, XES & MEME led gains as rate-cut hopes lifted markets.

Zacks Investment Research • Dec 8, 2025

MSOS: Focused Exposure To U.S. Cannabis Stocks

The AdvisorShares Pure US Cannabis ETF offers concentrated, actively managed exposure to the US cannabis industry via equities and swaps. MSOS is top-heavy, with 97% of net assets in its top 10 positions. Holdings are largely allocated to micro- and small-cap companies. Event-driven returns hinge on federal legalization momentum, particularly the potential passage of the MORE Act.

Seeking Alpha • Dec 4, 2025

MSOS Has HEMP THC Prohibition Issues

I maintain a Strong Sell on AdvisorShares Pure US Cannabis ETF due to excessive volatility and structural portfolio risks. MSOS is heavily concentrated, with 69% exposure to Curaleaf, Green Thumb Industries, and Trulieve, amplifying downside risk. Recent federal hemp THC prohibition threatens growth prospects for key MSOS holdings and may force write-downs.

Seeking Alpha • Dec 2, 2025

Marijuana ETFs Look to Supreme Court Legalization

Thematic ETFs have a long and storied history in the ETF ecosystem, offering investors ways to make sector bets, for example, or, craft a bespoke allocation with individual building blocks.

ETF Trends • Dec 2, 2025